Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of MAFIXIME Capsule vs Cefspan under fasting conditions
TCTR20230427006Phase 1Unknown
- Sponsor
- International Bio Service
- Start
- Oct 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of cefixime in bacterial disease (2 arms), sponsored by International Bio Service. Status: unknown.
02
Drugs
cefixime
03
Conditions
bacterial disease
Beyond the preview
Go deeper on TCTR20230427006.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20230427006.